We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Morphosys Receives Novartis Milestone Payment for Phase 1 Trial

News   Jul 05, 2016

 
Morphosys Receives Novartis Milestone Payment for Phase 1 Trial
 
 
 

RELATED ARTICLES

Immune System Kept in Check by Protein Police

News

Researchers learn how a key transcription factor helps regulate the immune system and could be critical to understanding autoimmune disease and cancer immunosuppression.

READ MORE

Probiotic Gives Long-standing Protection Against Childhood Eczema

News

Giving a probiotic supplement to pregnant mothers and their infants significantly reduces the chances of a child developing eczema for the first 11 years of their life.

READ MORE

Promise for an HIV Vaccine

News

An experimental vaccine strategy against HIV has been shown to work in non-human primates.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE